手当ての文化を、世界へ
久光製薬 (Hisamitsu Pharmaceutical) (hisamitsu.co.jp) earns a Brand Analyzer score of 57 out of 100, placing it in the Developing tier among Healthcare brands, Manufacturing brands. Among 2305 Healthcare brands analyzed, 久光製薬 (Hisamitsu Pharmaceutical) ranks in the 9th percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 82/100, Digital Presence 65/100, Visual Identity 93/100, Messaging Clarity 61/100, Trust Foundation 47/100, AI Discoverability 45/100, Brand Authority 30/100.
久光製薬 (Hisamitsu Pharmaceutical) is a Japanese drug company. It was founded in 1847. It is headquartered in Tokyo. 世界の人々のQOL向上を目指すことを経営理念とし、思いやりにあふれた商品・サービスの提供に積極的に取り組む。.
| Brand Name | 久光製薬 (Hisamitsu Pharmaceutical) |
|---|---|
| Domain | hisamitsu.co.jp |
| Industry | Healthcare, Manufacturing |
| Founded | 1847 |
| Headquarters | Tokyo |
| Main Competitors | Sato Pharmaceutical, Taisho Pharmaceutical, Kobayashi Pharmaceutical (52/100), Rohto Pharmaceutical, Pfizer (89/100) |
Moz Domain Authority 45/100 vs category average 29 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #390,995 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "久光製薬は、「世界の人々のQOL向上を目指す」を経営理念とし、『「手当て」の文化を、世界へ。』を企業使命と定め、思いやりにあふれた商品・サービスの提供に積極的に取り組んでまいります。" (Meta description too short (1 words). No OG description (falling back to meta)) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: No structured data or Open Graph tags detected. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on GitHub; no detected presence on X (Twitter), LinkedIn, Facebook, Instagram, YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
久光製薬 (Hisamitsu Pharmaceutical) scores 38/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
久光製薬 (Hisamitsu Pharmaceutical) has a weak AI-visibility profile at 38/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (66/100) and its weakest is trust (26/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #390,995 (Tranco) and a Moz Domain Authority of 45/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
久光製薬 (Hisamitsu Pharmaceutical)'s main competitors include Sato Pharmaceutical, Taisho Pharmaceutical, Kobayashi Pharmaceutical (52/100), Rohto Pharmaceutical, Pfizer (89/100). These companies compete in the Healthcare space for similar customers, offering comparable products or services.
久光製薬 (Hisamitsu Pharmaceutical) and Pfizer are competitors in Healthcare. Brand Analyzer scores 久光製薬 (Hisamitsu Pharmaceutical) at 57/100 and Pfizer at 89/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Popular alternatives to 久光製薬 (Hisamitsu Pharmaceutical) include Sato Pharmaceutical, Taisho Pharmaceutical, Kobayashi Pharmaceutical (52/100), Rohto Pharmaceutical, Pfizer (89/100). Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
久光製薬（Hisamitsu Pharmaceutical）は、1847年に創業した日本の製薬会社である。本社を東京に置き、「世界の人々のQOL向上を目指す」を経営理念、『「手当て」の文化を、世界へ。』を企業使命として定める。ヘルスケアおよび製造のカテゴリーに属し、医薬品ならびにOTC製品の提供を通じて患者・消費者の生活の質向上に取り組む企業である。
久光製薬 (Hisamitsu Pharmaceutical) has limited AI-search visibility, scoring 38/100 on Brand Analyzer's AI visibility composite (visibility 30, trust 26, recommendation 66). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
久光製薬 (Hisamitsu Pharmaceutical) was founded in 1847. 久光製薬 (Hisamitsu Pharmaceutical) operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
久光製薬 (Hisamitsu Pharmaceutical) is headquartered in Tokyo. 久光製薬 (Hisamitsu Pharmaceutical) operates in the Healthcare category.
Sources: Wikidata
久光製薬は、高品質な医薬品およびOTC製品を製造・提供する企業である。手掌多汗症などの疾患に対する治療薬を含む医薬品の開発・販売を行い、思いやりにあふれた商品・サービスを通じて世界の人々のQOL向上を目指している。また、「手当て」の文化を世界へ広げることを企業使命として積極的に事業展開している。
久光製薬 (Hisamitsu Pharmaceutical) scores 66/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
久光製薬は、高品質な医薬品およびOTC製品を提供している。具体的には手掌多汗症などの疾患に対する治療薬が挙げられる。また、思いやりにあふれた商品・サービスを幅広く展開しており、医療用医薬品と一般消費者向けのOTC製品の両分野にわたる製品ラインアップを持つとされる。
久光製薬 (Hisamitsu Pharmaceutical) can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
久光製薬の製品・サービスを利用するのは、手掌多汗症などの疾患を抱える患者、医療関係者、旅行者、一般消費者、および株主・投資家である。同社は幅広いターゲット層に向けて医薬品やヘルスケア製品を提供しており、患者から一般消費者まで多岐にわたるユーザーを対象としている。
久光製薬は、「手当て」の文化を世界に広げることを企業使命として掲げる日本の製薬会社として知られる。高品質な医薬品およびOTC製品の提供、特に手掌多汗症などの疾患に対する治療とQOL向上への取り組みで認知されている。1847年創業という長い歴史を持つ点も特徴の一つである。
Ranked closest to 久光製薬 (Hisamitsu Pharmaceutical): Healthcare Fraud Shield (57/100), SmartRecover (57/100), i2e (57/100), Kage Distribution, Inc. (57/100).
A step up - brands to learn from: Zipari by mPulse (71/100), Zaina AI (71/100).
Category leader: Dassault Systèmes (95/100).